Switzerland· 49389019
Robinul-Neostigmina, soluzione iniettabile
A neostigmin, kombinationen product containing glycopyrronii bromidum, neostigmini metilsulfas, registered in Switzerland by Sintetica SA and dispensed under Swissmedic category B. The same ATC class is registered in 6 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Neostigmin, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC N07AA51 (neostigmin, kombinationen), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 4 of them publish a price we can compare per daily dose
Neostigmin, kombinationen · ATC N07AA51
6 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- glycopyrronii bromidum, neostigmini metilsulfas
- Manufacturer
- Sintetica SA
- Country
- Switzerland (CH)
- ATC code
- N07AA51
- ATC class
- Neostigmin, Kombinationen
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neostigmin, kombinationen in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Novistig
- United Kingdom (Northern Ireland) · Glycopyrrolate And Neostigmine Metilsulfate Mercury Pharmaceuticals
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32d304d3-4667-4fc9-aaa0-a4c051bc3016 GET /v1/drugs/32d304d3-4667-4fc9-aaa0-a4c051bc3016?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about neostigmin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.